LANCHBURY JERRY S 4
4 · MYRIAD GENETICS INC · Filed Aug 6, 2021
Insider Transaction Report
Form 4
LANCHBURY JERRY S
See Remarks
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-08-05$27.07/sh+28,225$764,051→ 260,775 total - Sale
Common Stock
[F1][F2]2021-08-05$35.57/sh−28,225$1,004,008→ 232,550 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F3]2021-08-05−28,225→ 80,000 totalExercise: $27.07Exp: 2022-09-12→ Common Stock (28,225 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.57 to $35.60, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares subject to this option are fully vested and exercisable.
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury|2021-08-06